Alternate Health Corp. (OTCQB: AHGIF) (CSE: AHG) Rallies 21% After Announcing Strategic Shift In CBD Positioning

Alternate Health Corp. (OTCQB: AHGIF) (CSE: AHG) operates in the CBD industry, which includes extraction, product development, distribution, research, and more. The company’s subsidiary, Blaine Labs, is a cGMP medical product manufacturing and distribution business, “with over 50 product SKUs available from major retailers including Walmart, Amazon, CBS, and Walgreens,” according to the company. The U.S.-listed shares of the CBD…

Read More

Captor Capital Announces Availability of Updated Investor Presentation

Captor Capital Corp

TORONTO, May 14, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; USOTC: CPTRF; FRANKFURT: NMV; STUTTGART: NMVA;), (“Captor” or the “Company”), a vertically integrated cannabis investment company, is pleased to announce that a new investor presentation will be available on the Company website as of 9:00 a.m. today, May 14. The updated presentation is being released in conjunction with…

Read More

Idaho Champion Receives Drill Permit for 2019 Exploration Campaign at the Baner Project

Idaho Champion Gold Mines Canada Inc.

TORONTO, May 02, 2019 (GLOBE NEWSWIRE) — Idaho Champion Gold Mines Canada Inc. (CSE: ITKO) (“Champion” or the “Company”), a discovery-focused gold exploration company, has a signed Decision Memorandum from the US Forest Service that approves exploratory drilling on the Sally claim block.  See Idaho Champion’s press release October 15, 2018 on the purchase of the Sally clams.  Idaho Champion…

Read More

Valens GroWorks Corp. (CSE: VGW) (OTCQB: VGWCF) Looks Ready For a Breather Amid Melt-Up

So far in 2019, marijuana has been the place to be, as cannabis stocks have largely outperformed the overall market thus far through the end of April 2019. Two of the largest cannabis ETFs are up over 40% year-to-date: ETFMG Alternative Harvest ETF (NYSE: MJ) up 43% and the Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) up around 51%.…

Read More

FSD Pharma, Inc. (CSE: HUGE) (OTCQB: FSDDF) Rallies 20% After Receiving Medical Cannabis Sales License in Canada

FSD Pharma, Inc.

FSD Pharma, Inc. (CSE: HUGE) (OTCQB: FSDDF) is engaged as a Canada-based cannabis company that is primarily focused on high-quality indoor cultivation for medical-grade marijuana. Furthermore, FSD Pharma is working on the research and development of cannabis-based treatments for a wide-range of central nervous system ailments, such as chronic pain, fibromyalgia, irritable bowel syndrome and more. FSD Pharma’s Ontario cultivation…

Read More

Captor Capital Enters Into Letter of Intent to Acquire Majority Ownership in Michigan Cannabis Opportunity

captor capital

April 09, 2019 07:59 ET | Source: Captor Capital Corp. 20 retail cannabis licenses Two processing licenses Eight cultivation licenses TORONTO, April 09, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; USOTC: CPTRF; FRANKFURT: NMV; STUTTGART: NMVA), (“Captor” or the “Company”), a vertically integrated investment company focused on cannabis, is pleased to announce that it has entered into a…

Read More

Pivot Pharmaceuticals, Inc. (CSE: PVOT) (OTCQB: PVOTF) Surges 45% After Signing LOI with Pharmascience, Inc.

Pivot Pharmaceuticals, Inc.

Pivot Pharmaceuticals, Inc. (CSE: PVOT) (OTCQB: PVOTF) is a biopharmaceutical company focused on the development and commercialization of cannabis-based therapeutic pharmaceuticals, nutraceuticals, and drug delivery platform technologies. The company’s U.S.-listed shares surged 44.79% on Wednesday, April 3, 2019. Over the past month, Pivot has seen an average daily volume of 24,550 shares. However, on Wednesday, 239,787 shares traded hands, equating…

Read More

RETRANSMISSION – Captor Capital Announces Share Buyback Program

Captor Capital

 Company intends to purchase up to $5 million in shares TORONTO, Dec. 18, 2018 (GLOBE NEWSWIRE) — Captor Capital Corp. (“Captor” or the “Company”) (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; USOTC: NWURF), a cannabis-focused investment company, announced today its intention to commence a normal course issuer bid (“NCIB” or the “Bid“) to expend up to an aggregate of CDN $5 million on the…

Read More

Captor Capital Announces Share Buyback Program

Captor Capital Buy Back

 Company intends to purchase up to $5 million in shares TORONTO, Dec. 17, 2018 (GLOBE NEWSWIRE) — Captor Capital Corp. (“Captor” or the “Company”) (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; USOTC: NWURF), a cannabis-focused investment company, announced today its intention to commence a normal course issuer bid (“NCIB” or the “Bid“) to expend up to an aggregate of CDN $5 million on the…

Read More

Captor Capital Obtains Castroville Dispensary Licenses

Captor Capital Corp

C TORONTO, Dec. 13, 2018 (GLOBE NEWSWIRE) — Captor Capital Corp. (“Captor” or the “Company”) (CSE:CPTR; FRANKFURT:NMV; USOTC:NWURF)  is pleased to announce that the Higher Level Castroville dispensary has been awarded both state and local licenses to sell recreational cannabis. The licenses were awarded December 10th and the Company expects the deal to be finalized shortly. The Captor management team is now in the…

Read More